Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Genes 2Me Private Ltd
India · 6 relevant products
Medicover Genetics Ltd
Cyprus · 5 relevant products
YouSeq
United Kingdom · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
Nonacus
United Kingdom · 12 relevant products
Biopsense Oy
Finland · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
39 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
Medicover Genetics Ltd · Cyprus
Genetic testing for cancer predisposition and somatic cancer variants to identify individuals at risk or with diagnosed malignancies. Includes comprehensive sequencing with clinical validation and genetic counselling.
YouSeq · United Kingdom
An NGS-based panel for detection of inherited genetic mutations associated with hereditary cancer syndromes. Enables identification of cancer predisposition for risk stratification and preventive clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
Genes 2Me Private Ltd · India
Precision NGS panel containing 774 genes designed for oncology and clinical genomics applications. Enables comprehensive genetic profiling for accurate detection of clinically relevant variants in cancer diagnostics.
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.
YouSeq · United Kingdom
A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Genes 2Me Private Ltd · India
Sequencing panel for identifying genetic variations associated with hereditary and congenital disorders. Enables comprehensive genetic disease diagnosis.
GENETRON HEALTH (BEIJING) CO., LTD · China
A comprehensive genomic profiling test for tumor patients providing information on 831 cancer-related genes in a single test. The integrated analysis results support precision targeted therapy selection for cancer patients.
Nonacus · United Kingdom
Collection of pre-configured next-generation sequencing panels available for immediate clinical use. Enables rapid deployment of validated genomic testing workflows for common applications in oncology, constitutional genetics, and precision medicine.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Comprehensive diagnostic panel for personalized treatment selection in cardiovascular and oncology diseases. Analyzes multiple genetic and molecular markers to guide clinical decision-making.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products